- Home
- MCRI vs LMAT Comparison
MCRI vs LMAT Comparison
Compare MCRI & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRI
- LMAT
- Stock Information
- Founded
- MCRI 1972
- LMAT 1983
- Country
- MCRI United States
- LMAT United States
- Employees
- MCRI N/A
- LMAT N/A
- Industry
- MCRI Hotels/Resorts
- LMAT Medical/Dental Instruments
- Sector
- MCRI Consumer Discretionary
- LMAT Health Care
- Exchange
- MCRI Nasdaq
- LMAT Nasdaq
- Market Cap
- MCRI 1.9B
- LMAT 2.0B
- IPO Year
- MCRI 1993
- LMAT 2006
- Fundamental
- Price
- MCRI $96.31
- LMAT $87.38
- Analyst Decision
- MCRI Hold
- LMAT Buy
- Analyst Count
- MCRI 5
- LMAT 6
- Target Price
- MCRI $96.20
- LMAT $99.67
- AVG Volume (30 Days)
- MCRI 84.3K
- LMAT 166.8K
- Earning Date
- MCRI 10-21-2025
- LMAT 11-06-2025
- Dividend Yield
- MCRI 1.25%
- LMAT 0.92%
- EPS Growth
- MCRI N/A
- LMAT 22.69
- EPS
- MCRI 4.22
- LMAT 2.05
- Revenue
- MCRI $534,693,999.00
- LMAT $234,639,000.00
- Revenue This Year
- MCRI $6.87
- LMAT $16.27
- Revenue Next Year
- MCRI $4.19
- LMAT $8.29
- P/E Ratio
- MCRI $22.82
- LMAT $42.60
- Revenue Growth
- MCRI 4.65
- LMAT 14.11
- 52 Week Low
- MCRI $69.99
- LMAT $71.42
- 52 Week High
- MCRI $113.88
- LMAT $109.58
- Technical
- Relative Strength Index (RSI)
- MCRI 33.20
- LMAT 45.70
- Support Level
- MCRI $95.29
- LMAT $86.53
- Resistance Level
- MCRI $98.25
- LMAT $88.54
- Average True Range (ATR)
- MCRI 2.39
- LMAT 2.28
- MACD
- MCRI -1.01
- LMAT 0.03
- Stochastic Oscillator
- MCRI 12.02
- LMAT 62.50
About MCRI Monarch Casino & Resort Inc.
Monarch Casino & Resort Inc is engaged in providing the latest gaming, dining, and hospitality amenities. It owns and operates the Atlantis Casino Resort Spa, a hotel/casino facility in Reno, Nevada, and the Monarch Black Hawk Casino in Black Hawk. The company generates the majority of its revenue from Casinos, followed by Food & Beverage and Hotel Operations.
About LMAT LeMaitre Vascular Inc.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.